Description
Streptokinase Injection 2.5 / 5 / 7.5 / 15 Lac IU is used in
Acute Evolving Transmural Myocardial Infarction: Streptokinase, is indicated for use in the management of acute myocardial infarction (AMI) in adults, for the iysis of intracoronary thrombi, the improvement of ventricular function, and the reduction of mortality associated with AMI, when administered by either the intravenous or the intracoronary route, as well as for the reduction of infarct size and congestive heart failure associated with AMI when administered by the intravenous route.
Pulmonary Embolism: Streptokinase, is indicated for the lysis of objectively diagnosed (angiography or lung scan) pulmonary emboli, involving obstruction of blood flow to a lobe or multiple segments, with or without unstable hemodynamics.
Deep Vein Thrombosis: Streptokinase, is indicated for the lysis of objectively diagnosed (preferably ascending venography), acute, extensive thrombi of the deep veins such as those involving the popliteal and more proximal vessels.
Arterial Thrombosis or Embolism: Streptokinase, is indicated for the lysis of acute arterial thrombi and emboli. Streptokinase is not indicated for arterial emboli originating from the left side of the heart due to the risk of new embolic phenomena such as cerebral embolism.
Occlusion of Arteriovenous Cannulae: Streptokinase, is indicated as an alternative to surgical revision for clearing totally or partially occluded arteriovenous cannulae when acceptable flow cannot be achieved.
There are many generic manufacturers in India who manufacture Streptokinase Injection 2.5 / 5 / 7.5 / 15 Lac IU including Zydus Cadila Healthcare ,Biocon(India)Ltd and Piramal Healthcare etc.
3s corporation is Supplier,Exporter ,Wholesaler for Streptokinase Injection 2.5 / 5 / 7.5 / 15 Lac IU in India.